NMRA Neumora Therapeutics Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: NMRA

Price (delayed)

$0.7313

Market cap

$137.41M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.23

Enterprise value

$73.83M

?
Relative Growth: Rel. Growth: 11
Relative Strength: Rel. Strength: 2
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 5
Highlights
The company's EPS rose by 22% YoY and by 8% QoQ
The net income is up by 16% year-on-year and by 4.3% since the previous quarter
The debt has soared by 167% YoY
Neumora Therapeutics's equity has shrunk by 76% YoY and by 37% QoQ
Sector: Healthcare
Industry: Biotechnology
Website: https://neumoratx.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of NMRA

NMRA stock price

How has the Neumora Therapeutics stock price performed over time
Intraday
-6.06%
1 week
-5.42%
1 month
-55.13%
1 year
-61.71%
YTD
-59.15%
QTD
-56.98%

Financial performance

How have Neumora Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$211.23M
Net income
-$212.75M
Gross margin
N/A
Net margin
N/A
Neumora Therapeutics's operating income has increased by 20% YoY and by 5% QoQ
The net income is up by 16% year-on-year and by 4.3% since the previous quarter

Price vs fundamentals

How does NMRA's price correlate with its fundamentals

Growth

What is Neumora Therapeutics's growth rate over time

Valuation

What is Neumora Therapeutics stock price valuation
P/E
N/A
P/B
3.04
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS rose by 22% YoY and by 8% QoQ
Neumora Therapeutics's equity has shrunk by 76% YoY and by 37% QoQ
The stock's P/B is 25% below its last 4 quarters average of 4.3

Efficiency

How efficient is Neumora Therapeutics business performance
The ROE has plunged by 145% YoY and by 33% from the previous quarter
NMRA's return on invested capital has dropped by 133% year-on-year and by 39% since the previous quarter
The ROA has contracted by 50% YoY and by 10% from the previous quarter

Dividends

What is NMRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NMRA.

Financial health

How did Neumora Therapeutics financials performed over time
The company's total assets is 55% higher than its total liabilities
The company's total liabilities has surged by 97% YoY but it fell by 3% QoQ
Neumora Therapeutics's quick ratio has shrunk by 59% YoY and by 14% QoQ
The debt is 20% more than the equity
The debt has soared by 167% YoY
Neumora Therapeutics's equity has shrunk by 76% YoY and by 37% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.